NEW YORK (GenomeWeb) – PGXL Technologies said on Monday it has been awarded $149,910 to fund the development of a platform for isolating and analyzing circulating tumor cells in breast cancer.

The funding is being awarded through the Kentucky Small Business Innovation Research and Small Business Technology Transfer Matching Funds program, and will be used to match a National Institutes of Health/National Cancer Institute grant contract awarded to PGXL in the fall, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.